Our findings demonstrate that CAP treatment could induce M2 polarization of macrophages, trigger IL-10 release, subsequently activate the STAT1/STAT3 signaling pathway to alleviate ER stress caused by CAP, and ultimately suppress the programmed cell death in lung cancer cells, including apoptosis, pyroptosis and autophagy. Here, STAT1 is linked to lung cancer.